Thank you to our speakers, sponsors, and delegates who joined us in Berlin!


3rd mRNA Analytical Development Summit
Boston, MA | 13th-15th February, 2024

Welcome to the mRNA Analytical Development Summit Europe:
Revolutionising Optimised Analytics to Support World-Class mRNA Medicines

Comprehensive analytical support has been crucial to the global success of mRNA medicines. As drug development timelines become more demanding, accessing novel, optimised, and high-throughput analytical methods is essential to guarantee the approval and commercialisation of safe and effective mRNA therapeutics and vaccines.

The inaugural mRNA Analytical Development Summit Europe was the only industry-dedicated forum to showcase critical expertise and the latest techniques in optimised analytics for leading European biopharma. Taking place in Berlin August 2023, the meeting highlighted the importance of advanced analytical approaches and adherence to regulatory requirements, as the European market continues to capitalise on these strategies.

Next year is your opportunity to join the main industry players as they navigate through their case studies and share their experiences!

Download the complete 2023 brochure here.

The 2023 Expert Speaker Faculty Included:

This must-attend meeting was designed for Analytical Development, Quality Control, CMC, and Regulatory Experts seeking to stay at the forefront of mRNA therapeutic and vaccine development. 80+ experts from across Europe joined us in August to provide attendees with a better understanding of future analytical methods to safeguard your regulatory submissions in 2023 and beyond.

Avoid missing out in 2024 on networking with those shaping the landscape of novel and emerging analytical tools and technologies for mRNA-based therapeutics and vaccines.

2024 Will Be Another Opportunity To Meet Your Community Face-to-Face to Address the Industry's Biggest Challenges:

Discuss Critical Regulatory Insights for Guidance on Requirements of the Analytical Field of mRNA-based Therapeutics & Vaccines

Review the most updated opportunities and learnings that the regulatory agencies are requesting, as well as leading biopharma companies’ strategies to streamline your mRNA therapeutics through approval with insights from Paul Elrich Institute & Roche

Review the Essential Considerations for Purifying & Characterising mRNA Therapeutics

Explore the advances in overcoming purification challenges for mRNA product development to create a successful and purified mRNA medicine with insights from the University of Pennsylvania & CureVac

Understand Ways to Develop & Manufacture Consistent Quality LNPs For Efficient mRNA Drug Delivery

Uncover why the production of LNPs with specific sizes and PDI according to the regulatory requirement remains a challenge in mRNA delivery and what the advances are to overcome this bottleneck with insights from Moderna & Bayer

Delve into the Advancements in In Vitro & In Vivo Testing to Optimise Your mRNA Therapeutics

Investigate the emerging approaches of in vitro translation for improved characterisation of the physical structure of protein and how to narrow the gap between in vitro and in vivo genetic profiles with insights from Nava Therapeutics & the University of Copenhagen

Address the Key Analytical Challenges in mRNA Vaccines & How to Overcome Them to Ensure a Safe & Efficient mRNA Vaccine

Explore the approaches used for analysing potency in mRNA vaccines and challenges surrounding testing the potency of similar antigen sequences with insights from GSK & BioNTech

Our 2023 Partners